Devaraj Ezhilarasan

4.2k total citations
104 papers, 2.5k citations indexed

About

Devaraj Ezhilarasan is a scholar working on Pharmacology, Epidemiology and Hepatology. According to data from OpenAlex, Devaraj Ezhilarasan has authored 104 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 32 papers in Epidemiology and 26 papers in Hepatology. Recurrent topics in Devaraj Ezhilarasan's work include Drug-Induced Hepatotoxicity and Protection (31 papers), Liver Disease Diagnosis and Treatment (29 papers) and Liver physiology and pathology (21 papers). Devaraj Ezhilarasan is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (31 papers), Liver Disease Diagnosis and Treatment (29 papers) and Liver physiology and pathology (21 papers). Devaraj Ezhilarasan collaborates with scholars based in India, Belgium and Saudi Arabia. Devaraj Ezhilarasan's co-authors include S Gheena, Mustapha Najimi, Étienne Sokal, Lakshmi Thangavelu, S. Rajeshkumar, Rajeshkumar Shanmugam, Sivanesan Karthikeyan, Raghunandhakumar Subramanian, Anitha Roy and Elumalai Perumal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and European Journal of Pharmacology.

In The Last Decade

Devaraj Ezhilarasan

99 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devaraj Ezhilarasan India 28 541 508 448 448 419 104 2.5k
Yuanyuan Zhang China 37 692 1.3× 2.0k 3.9× 173 0.4× 142 0.3× 308 0.7× 209 4.7k
Hyun‐Jung Lee South Korea 34 507 0.9× 835 1.6× 142 0.3× 113 0.3× 101 0.2× 180 3.5k
Santosh Kumar Singh India 17 208 0.4× 1.4k 2.7× 52 0.1× 167 0.4× 113 0.3× 84 2.8k
Yi Wang China 33 376 0.7× 2.0k 3.9× 78 0.2× 62 0.1× 144 0.3× 296 4.6k
Tong‐Hong Wang Taiwan 29 121 0.2× 1.0k 2.0× 174 0.4× 54 0.1× 123 0.3× 82 2.1k
Yiyang Hu China 39 1.4k 2.5× 2.1k 4.1× 28 0.1× 609 1.4× 561 1.3× 223 5.2k
Junaid Khan Pakistan 31 195 0.4× 790 1.6× 48 0.1× 39 0.1× 224 0.5× 124 2.9k
Despina Perrea Greece 35 856 1.6× 951 1.9× 84 0.2× 76 0.2× 62 0.1× 249 5.3k
Harjeet Singh India 20 201 0.4× 203 0.4× 128 0.3× 58 0.1× 44 0.1× 175 1.7k
Lijie Zhang China 36 523 1.0× 1.8k 3.5× 24 0.1× 145 0.3× 97 0.2× 225 4.4k

Countries citing papers authored by Devaraj Ezhilarasan

Since Specialization
Citations

This map shows the geographic impact of Devaraj Ezhilarasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devaraj Ezhilarasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devaraj Ezhilarasan more than expected).

Fields of papers citing papers by Devaraj Ezhilarasan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devaraj Ezhilarasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devaraj Ezhilarasan. The network helps show where Devaraj Ezhilarasan may publish in the future.

Co-authorship network of co-authors of Devaraj Ezhilarasan

This figure shows the co-authorship network connecting the top 25 collaborators of Devaraj Ezhilarasan. A scholar is included among the top collaborators of Devaraj Ezhilarasan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devaraj Ezhilarasan. Devaraj Ezhilarasan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ezhilarasan, Devaraj, et al.. (2024). Molecular insights on intracellular Wnt/β‐catenin signaling in alcoholic liver disease. Cell Biochemistry and Function. 42(1). e3916–e3916. 6 indexed citations
2.
Ezhilarasan, Devaraj, et al.. (2024). Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress. Journal of Drug Delivery Science and Technology. 93. 105467–105467. 8 indexed citations
3.
Ezhilarasan, Devaraj, et al.. (2024). Boldine protects against carbon tetrachloride‐induced chronic liver injury by regulating NF‐κB signaling pathway. Journal of Biochemical and Molecular Toxicology. 38(4). e23691–e23691. 5 indexed citations
4.
Ezhilarasan, Devaraj & Langeswaran Kulanthaivel. (2024). Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD. Cell Biochemistry and Function. 42(7). 8 indexed citations
5.
Ezhilarasan, Devaraj, et al.. (2023). Coleus vettiveroides ethanolic root extract protects against thioacetamide‐induced acute liver injury in rats. Cell Biochemistry and Function. 41(7). 876–888. 5 indexed citations
6.
Ezhilarasan, Devaraj, et al.. (2023). Nanodrug delivery: Strategies to circumvent nanoparticle trafficking by Kupffer cells in the liver. Journal of Drug Delivery Science and Technology. 86. 104731–104731. 16 indexed citations
7.
Mani, Uthirappan, et al.. (2023). Antibacterial Properties of Metal and Metal Oxide Nanoparticles-An Overview. 33–49. 8 indexed citations
8.
Ezhilarasan, Devaraj. (2023). Unraveling the pathophysiologic role of galectin‐3 in chronically injured liver. Journal of Cellular Physiology. 238(4). 673–686. 13 indexed citations
9.
Ezhilarasan, Devaraj, et al.. (2023). Coleus vettiveroides ethanolic root extract induces cytotoxicity by intrinsic apoptosis in HepG2 cells. Journal of Applied Toxicology. 44(2). 245–259. 4 indexed citations
10.
Ezhilarasan, Devaraj, et al.. (2021). The ambiguous role of sirtuins in head and neck squamous cell carcinoma. Oral Diseases. 28(3). 559–567. 46 indexed citations
11.
Ezhilarasan, Devaraj, et al.. (2021). β-sitosterol induces reactive oxygen species-mediated apoptosis in human hepatocellular carcinoma cell line. SHILAP Revista de lepidopterología. 14 indexed citations
12.
Perumal, Elumalai, Devaraj Ezhilarasan, & Raghunandhakumar Subramanian. (2021). Molecular Targets of Nimbolide for Anti-Cancer Therapy: An Updated Review. Journal of Environmental Pathology Toxicology and Oncology. 41(2). 69–88. 5 indexed citations
13.
Ezhilarasan, Devaraj, Daoud Ali, & Rakesh Varghese. (2021). Sesamol induces cytotoxicity via mitochondrial apoptosis in SCC-25 cells. Human & Experimental Toxicology. 40(12_suppl). S423–S433. 4 indexed citations
14.
Ezhilarasan, Devaraj. (2021). Deciphering the toxicological role of Porphyromonas gingivalis derived endotoxins in liver diseases. Environmental Toxicology and Pharmacology. 88. 103755–103755. 4 indexed citations
15.
Thangavelu, Lakshmi, Sri Renukadevi Balusamy, S. Rajeshkumar, et al.. (2020). Evaluation of the sub-acute toxicity of Acacia catechu Willd seed extract in a Wistar albino rat model. Regulatory Toxicology and Pharmacology. 113. 104640–104640. 17 indexed citations
16.
Ezhilarasan, Devaraj. (2020). Critical role of estrogen in the progression of chronic liver diseases. Hepatobiliary & pancreatic diseases international. 19(5). 429–434. 62 indexed citations
17.
Ezhilarasan, Devaraj. (2020). MicroRNA interplay between hepatic stellate cell quiescence and activation. European Journal of Pharmacology. 885. 173507–173507. 83 indexed citations
18.
Ezhilarasan, Devaraj, et al.. (2019). Safety evaluation of an antiviral polyherbal drug of Siddha Medicine in Wistar rats. 18(3). 531–535. 2 indexed citations
19.
Ezhilarasan, Devaraj, et al.. (2018). In vitro Antifungal Effects of Hesperetin and Silibinin. Pharmacognosy Journal. 10(4). 789–792. 4 indexed citations
20.
Ezhilarasan, Devaraj, et al.. (2017). Acacia catechu ethanolic seed extract triggers apoptosis of SCC-25 cells. Pharmacognosy Magazine. 13(51). 405–405. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanyuan Zhang Breakdown of academic impact, for papers by Hyun‐Jung Lee Breakdown of academic impact, for papers by Santosh Kumar Singh Breakdown of academic impact, for papers by Yi Wang Breakdown of academic impact, for papers by Tong‐Hong Wang Breakdown of academic impact, for papers by Yiyang Hu Breakdown of academic impact, for papers by Junaid Khan Breakdown of academic impact, for papers by Despina Perrea Breakdown of academic impact, for papers by Harjeet Singh Breakdown of academic impact, for papers by Lijie Zhang
Rankless by CCL
2026